| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | Nils G Morgenthaler | |
| P2860 | cites work | Changes in plasma copeptin, the c-terminal portion of arginine vasopressin during water deprivation and excess in healthy subjects. | Q34005206 |
| P921 | main subject | circulatory system | Q11068 |
| biomarker | Q864574 | ||
| P304 | page(s) | S37-44 | |
| P577 | publication date | 2010-07-01 | |
| P1433 | published in | Congestive Heart Failure | Q15756697 |
| P1476 | title | Copeptin: a biomarker of cardiovascular and renal function | |
| P478 | volume | 16 Suppl 1 |
| Q60045608 | A multicentre, randomized, controlled open-label trial to compare an Accelerated Rule-Out protocol using combined prehospital copeptin and in-hospital high sensitive troponin with standard rule-out in patients suspected of acute Myocardial Infarction |
| Q104459235 | A multivariable miRNA signature delineates the systemic hemodynamic impact of arteriovenous shunt placement in a pilot study |
| Q97073537 | Adverse Cardiac Remodelling after Acute Myocardial Infarction: Old and New Biomarkers |
| Q64091613 | Age-dependent impairment of the erythropoietin response to reduced central venous pressure in HFpEF patients |
| Q89405522 | Association of arginine vasopressin with low atrial natriuretic peptide levels, left ventricular remodelling, and outcomes in adults with and without heart failure |
| Q38353580 | Beyond cardiac troponin: recent advances in the development of alternative biomarkers for cardiovascular disease |
| Q37997820 | Biomarkers in community-acquired pneumonia |
| Q38232835 | Cardiac biomarkers for infarct diagnosis and early exclusion of acute coronary syndrome |
| Q26991726 | Cardiac biomarkers: new tools for heart failure management |
| Q35606726 | Changes in Plasma Copeptin Levels during Hemodialysis: Are the Physiological Stimuli Active in Hemodialysis Patients? |
| Q34248479 | Circulating levels of copeptin predict outcome in patients with pulmonary arterial hypertension |
| Q62734448 | Clinical relevance of copeptin plasma levels as a biomarker of disease severity and mortality in critically ill patients |
| Q64986825 | Clinical role of serum Copeptin in acute coronary syndrome. |
| Q26859111 | Clinical usefulness of novel serum and imaging biomarkers in risk stratification of patients with stable angina |
| Q49169613 | Combination of copeptin and troponin assays to rapidly rule out non-ST elevation myocardial infarction in the emergency department. |
| Q45897866 | Copeptin and MR-proADM in umbilical cord plasma reflect perinatal stress in neonates born to mothers with diabetes and MR-proANP reflects maternal diabetes. |
| Q38249996 | Copeptin as a biomarker in heart failure |
| Q39418430 | Copeptin concentrations are not elevated in gestational diabetes mellitus |
| Q42776150 | Copeptin in relation to New York Heart Association class in heart transplant recipients and kidney transplant recipients |
| Q38705713 | Copeptin in the diagnosis of vasopressin-dependent disorders of fluid homeostasis. |
| Q35433105 | Copeptin is an independent predictor of diabetic heart disease and death |
| Q90150814 | Copeptin levels in patients with coronary artery ectasia |
| Q36060397 | Copeptin, Insulin Resistance, and Risk of Incident Diabetes in Older Men. |
| Q37193463 | Copeptin, a surrogate marker for arginine vasopressin, is associated with cardiovascular and all-cause mortality in patients with type 2 diabetes (ZODIAC-31). |
| Q36073153 | Detection of copeptin in peripheral blood of patients with aneurysmal subarachnoid hemorrhage |
| Q57101391 | Diagnostic accuracy of adding copeptin to cardiac troponin for non-ST-elevation myocardial infarction: A systematic review and meta-analysis |
| Q90262618 | Effect of Chronic Kidney Disease on Changes in Vasopressin System Expression in the Kidney Cortex in Rats with Nephrectomy |
| Q36329310 | Effect of increased water intake on plasma copeptin in patients with chronic kidney disease: results from a pilot randomised controlled trial |
| Q58721092 | Effect of plasma sodium concentration on blood pressure regulators during hemodialysis: a randomized crossover study |
| Q62084082 | Failure of renal biomarkers to predict worsening renal function in high-risk patients presenting with oliguria |
| Q40526444 | Higher copeptin levels are associated with worse outcome in patients with hypertrophic cardiomyopathy |
| Q55340981 | Impact of acute versus prolonged exercise and dehydration on kidney function and injury. |
| Q41368070 | MR-proADM Predicts Exercise Capacity and Survival Superior to Other Biomarkers in PH. |
| Q37556419 | Neurohormonal Activation After Atrial Fibrillation Initiation in Patients Eligible for Catheter Ablation: A Randomized Controlled Study. |
| Q35692595 | No Added Value of Novel Biomarkers in the Diagnostic Assessment of Patients Suspected of Acute Coronary Syndrome |
| Q33792317 | Pathophysiology of copeptin in kidney disease and hypertension |
| Q36965316 | Plasma Copeptin, AVP Gene Variants, and Incidence of Type 2 Diabetes in a Cohort From the Community. |
| Q89574976 | Plasma copeptin and chronic kidney disease risk in 3 European cohorts from the general population |
| Q57052265 | Plasma copeptin is associated with type 2 diabetes in men but not in women in the population-based KORA F4 study |
| Q37306950 | Plasma copeptin levels are inversely associated with intima-media-thickness in men: the population-based KORA F4 study |
| Q91901217 | Point-of-care testing (POCT): Current techniques and future perspectives |
| Q39185614 | Prognostic Biomarkers in Acute Coronary Syndromes: Risk Stratification Beyond Cardiac Troponins |
| Q35791241 | Prognostic role of copeptin after stroke: A systematic review and meta-analysis of observational studies |
| Q45352471 | Revisiting vasopressin and heart failure |
| Q37228951 | Role of enteroendocrine L-cells in arginine vasopressin-mediated inhibition of colonic anion secretion |
| Q64245433 | Serum copeptin might improve risk stratification and management of aortic valve stenosis: a review of pathophysiological insights and practical implications |
| Q47104362 | The Effect of Renal Function and Hemodialysis Treatment on Plasma Vasopressin and Copeptin Levels |
| Q38788956 | The potential of optimizing prehospital triage of patients with suspected acute myocardial infarction using high-sensitivity cardiac troponin T and copeptin |
| Q35821307 | The ultimate nanoscale mincer: assembly, structure and active sites of the 20S proteasome core. |
| Q39442697 | Use of copeptin in emergency patients with cardiac chief complaints |
| Q48015191 | Validation of Surrogates of Urine Osmolality in Population Studies |
| Q38084471 | Vasopressin: a novel target for the prevention and retardation of kidney disease? |
| Q60916565 | Water Intake, Water Balance, and the Elusive Daily Water Requirement |
Search more.